Mifamurtide sodium is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults, which is lethal in about a third of cases. The drug was approved in Europe in March 2009. References: Mifamurtide: osteosarcoma: ineffective and harmful. Prescrire Int. 2011 Apr;20(115):89. PubMed PMID: 21648206.

纯度：≥98%

CAS：90825-43-7